Interpace Biosciences Inc News

10-Q: Q2 2024 Earnings Report

Aug 8 16:20 ET

8-K: Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results

Aug 2 16:36 ET

8-K: Interpace Biosciences Announces First Quarter 2024 Financial and Business Results

May 9 16:35 ET

10-Q: Q1 2024 Earnings Report

May 9 16:26 ET

10-K/A: Annual report (Amendment)

Apr 26 16:45 ET

Interpace Biosciences Inc | 10-K: FY2023 Annual Report

Apr 1 17:03 ET

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

Mar 13 12:52 ET

Interpace Biosciences Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Douglas M. Singer(5.78%)

Feb 12 17:06 ET

Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Christopher

Feb 6 06:36 ET

Interpace Biosciences Inc | 8-K: Current report

Dec 12, 2023 16:05 ET

Interpace Biosciences Inc | 8-K: Current report

Nov 16, 2023 16:05 ET

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results

Nov 8, 2023 17:14 ET

Interpace Biosciences Inc | 10-Q: Quarterly report

Nov 8, 2023 16:16 ET

Interpace Biosciences Inc | 8-K: Current report

Oct 27, 2023 16:05 ET

Interpace Biosciences Inc | DEFA14A: Others

Sep 22, 2023 16:53 ET

Interpace Biosciences Inc | DEF 14A: Definitive information statements

Sep 22, 2023 16:20 ET

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

Aug 9, 2023 15:47 ET

Interpace Biosciences Inc | 10-Q: Q2 2023 Earnings Report

Aug 9, 2023 13:27 ET

Interpace Biosciences Inc | 8-K: Current report

Aug 1, 2023 20:59 ET

Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer McCarthy Christopher

Aug 1, 2023 17:24 ET